Visa Inc. (NYSE:V)

VISA operates the world’s largest retail electronic payments network and is one of the most recognized global financial services brands. Visa facilitates global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses and government entities.

Visa Inc. (NYSE:V)’s Financial Overview

Visa Inc. (NYSE:V) surged 0.09% yesterday to close its trading session at $79.15. The company has 1 year Price Target of $93.7. Visa Inc. has 52-Week high of $83.96 and 52-Week Low of $66.12. The stock touched its 52-Week High on Nov 10, 2016 and 52-Week Low on Feb 9, 2016. The stock traded with the volume of 8.57 Million shares yesterday. The firm shows the market capitalization of $185.17 Billion.

Visa Inc. (NYSE:V) reported its last quarterly earnings on Sep 16 where the firm reported its Actual EPS of $0.78/share against the analyst consensus estimate of $0.73/share. The difference between the actual and expected EPS is $0.05 a share with a surprise factor of 6.8%.

The firm is trading with SMA20 of -2 Percent, SMA50 of -3.13 Percent and SMA200 of 0.97 percent. Visa Inc. has P/S value of 12.28 while its P/B value stands at 6.86. Similarly, the company has Return on Assets of 10 percent, Return on Equity of 20 percent and Return on Investment of 13.6 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 52.3 percent respectively.

Many brokerage firms are involved in issuing their ratings on Visa Inc. (NYSE:V). On 25-Oct-16 Guggenheim Downgrade Visa Inc. Stock  to Neutral. Another firm also rated the stock on 15-Apr-16 where Compass Point Initiated the stock to Neutral.

The Stock currently has Analyst’ mean Recommendation of 2 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 31 analysts offering 12-month price forecasts for Visa have a median target of 94.00, with a high estimate of 104.00 and a low estimate of 76.00. The median estimate represents a +18.76% increase from the last price of 79.15.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

CombiMatrix Corporation (NASDAQ:CBMX)

CombiMatrix Corporation is a diversified biotechnology business that develops proprietary technologies, including products and services in potential markets where their products and services can be utilized. The Company’s products and services are specially utilized in the areas of drug development, genetic analysis, molecular diagnostics, nanotechnology and defense and homeland security markets. The technologies they have developed include a platform technology to rapidly produce user-defined, in-situ synthesized, oligonucleotide arrays for use in identifying and determining the roles of genes, gene mutations and proteins. This technology has a wide range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences and nanotechnology. Other technologies include proprietary molecular synthesis and screening methods for the discovery of potential new drugs.

CombiMatrix Corporation (NASDAQ:CBMX)’s Financial Outlook

The 2 analysts offering 12-month price forecasts for CombiMatrix Corp have a median target of 6.00, with a high estimate of 6.60 and a low estimate of 5.40. The median estimate represents a +96.72% increase from the last price of 3.05.

Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.

According to Zacks Investment Research, CombiMatrix Corporation has a Consensus Recommendation of 1. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock gained 12.96% and closed its last trading session at $3.05. The company has the market capitalization of $7.66 Million. The stock has 52-week high of $14.7 and 52-Week low of $2.15. The firm touched its 52-Week high on Dec 23, 2015 and 52-Week low on Oct 28, 2016. The company has volume of 8.53 Million shares. The company has a total of 2.51 Million shares outstanding.

CombiMatrix Corporation (NASDAQ:CBMX) in the last quarter reported its actual EPS of $-0.38/share where the analyst estimated EPS was $-0.45/share. The difference between the actual and Estimated EPS is $0.07. This shows a surprise factor of 15.6 percent.

The company has YTD performance of -72.15 percent. Beta for CombiMatrix Corporation stands at 0.78 while its ATR (average true range) is 0.35. The company has Weekly Volatility of 15.88%% and Monthly Volatility of 12.04%%.

CombiMatrix Corporation has distance from 20-day Simple Moving Average (SMA20) of 18.68%, Distance from 50-Day Simple Moving Average of 13.88 percent and Distance from 200-Day Simple Moving Average of -8.34%.

The Company currently has ROA (Return on Assets) of -73.4 percent, Return on Equity (ROE) of -95.3 Percent and Return on Investment (ROI) of -105.5% with Gross margin of 52.2 percent and Operating & Profit margin of -42.3% and -57.7% respectively.

 

SHARE